Solifenacin

Chronic Conditions

Solifenacin

Generic For Vesicare®

starting at $29.99

Solifenacin is used to treat overactive bladder in adults with symptoms of urinary frequency, urgency, or urge incontinence. Solifenacin works by relaxing the muscles around the bladder so it can hold more liquid.

Solifenacin is used to treat overactive bladder in adults with symptoms of urinary frequency, urgency, or urge incontinence.

Typical dosing is 5 to 10 mg once daily

Efficacy is seen within 4 weeks of daily use

Select Dosage (Must Click Below)

Select Dosage (Select After Clicking Dosage)

Quantity (Select After Clicking Dosage)

Subscription

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Solifenacin

By clicking the “I Agree” button below, you certify under penalty of perjury that the following statements are true and correct and understand that a medical provider will rely on the truthfulness of your statements when determining whether a prescription is warranted and appropriate.

I agree that I:

am 18 to 65 years of age
have not had a hypersensitivity reaction to solifenacin or any component of the formulation
do not have urinary retention
do not have gastric retention
do not have uncontrolled narrow-angle glaucoma
have a diagnosis of overactive bladder and have already been taking solifenacin as prescribed by an authorized healthcare provider
do not have hepatic impairment or disease
do not have renal impairment or disease
understand that if my renal function is of a creatinine clearance of less than 30 ml/min then the maximum dose of solifenacin I can take is 5 mg daily.
am not pregnant nor breastfeeding
understand solifenacin is identified in the Beers Criteria as a potentially inappropriate medication in patients 65 years and older due to its strong anticholinergic properties
understand solifenacin is to be used with caution in the following medication conditions: Alzheimer disease, glaucoma, hepatic impairment, QT prolongation, renal impairment
understand use of solifenacin is associated with anticholinergic adverse reactions including but not limited to CNS effects (eg, confusion, dizziness, drowsiness, hallucinations), gastrointestinal effects (eg, constipation, dry mouth), ophthalmic effects (eg, blurred vision), cardiovascular effects (eg, prolonged QT interval on ECG) in adult and pediatric patients.
have already been taking the initial dose (solifenacin 5 mg) or have been previously prescribed solifenacin 10 mg if selecting solifenacin 10 mg
will not drink grapefruit juice with solifenacin
Do not nor intend to take the following drugs concurrently with solifenacin due to severe or major drug-drug interactions: aclidinium, cimetropium, clozapine, eluxadoline, fexinidazole, systemic fusidic acid, glycopyrrolate oral inhalation, glycopyrronium topical, ipratropium oral inhalation, itraconazole, levosulpride, oxatomide, potassium chloride, potassium citrate, pramlintide, revefenacin, rivastigmine, secretin, tiotropium, umeclidinium
Understand I can find more information regarding drug-drug interactions at https://www.drugs.com/drug_interactions.html
understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication
understand that only major drug interactions are listed and have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by TelyRx

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Solifenacin Side Effects

Solifenacin potential side effects may include: constipation, headache, blurred vision, dry mouth, fatigue, dry eyes
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.